Ward is a director at Deloitte, based in Brussels, where he is responsible for the manufacturing consulting practice. He worked in small and large molecules production environments across the globe as a consultant, and has extensive expertise in cell -and gene manufacturing. Throughout his career, he served large and small pharmaceutical companies and has been involved in every stage of a digital transformation, from strategic planning to multi-year MES and smart factory implementations.

“Deloitte” is the brand under which tens of thousands of dedicated professionals in independent firms throughout the world collaborate to provide audit, tax, financial advisory and consulting services to select clients. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited (“DTTL”), its global network of member firms, and their related entities (collectively, the “Deloitte organization”). DTTL (also referred to as “Deloitte Global”) and each of its member firms and related entities are legally separate and independent entities, which cannot obligate or bind each other in respect of third parties. DTTL and each DTTL member firm and related entity is liable only for its own acts and omissions, and not those of each other. DTTL does not provide services to clients. Please see www.deloitte.com/de/UeberUns to learn more.